This paper reexamines how a shift in demand for pharmaceutical treatments affects innovation as measured by new patent filings. Using U.S. Patent & Trademark Office data on pharmaceutical patenting between 1998-2019 for 40 drug therapeutic classes, I show that the announcement of expanded drug...